Enterprise Value
-7.07M
Cash
13.11M
Avg Qtr Burn
-9.073M
Short % of Float
0.24%
Insider Ownership
0.10%
Institutional Own.
12.28%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
HEPA-CRV431-210 (rencofilstat) Details Non-alcoholic steatohepatitis , Hepatitis B | Phase 2b Update | |
HEPA-CRV431-207 (rencofilstat) Details Hepatitis B, Non-alcoholic steatohepatitis | Failed Discontinued |